Downward price corrections and volatility experienced by RxSight stock are frequently driven by market reactions to revised financial revenue guidance, slower-than-expected adoption curves among certain eye care clinics, and competitive pressures within the premium ophthalmology sector. Additionally, lower-than-projected quarterly earnings or broader macroeconomic sell-offs affecting small-cap medical growth stocks can trigger institutional capital outflows. Class-action securities lawsuits investigating corporate disclosures have also contributed to negative sentiment and short-term downward pressure.